PAX2 Protein Induces Expression of Cyclin D1 through Activating AP-1 Protein and Promotes Proliferation of Colon Cancer Cells*

  1. Jing Fang,1
  1. From the Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China,
  2. the §Department of Surgery, Zhongshan Hospital, Fudan University School of Medicine, Shanghai 200030, China, and
  3. the Vivian L. Smith Department of Neurosurgery, Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas 77030
  1. 1 To whom correspondence should be addressed. Tel.: 86-21-54920241; Fax: 86-21-54920291; E-mail: jfang{at}sibs.ac.cn.

Background: PAX2, a transcription factor, plays a role in embryogenesis.

Results: Knockdown of PAX2 inhibits colon cancer cells proliferation and xenograft growth. PAX2 activates AP-1, leading to increased expression of cyclin D1.

Conclusion: PAX2 promotes proliferation of colon cancer cells via AP-1.

Significance: PAX2 exhibits oncogenic properties in colon cancer cells and may serve as a target for cancer therapy.

Abstract

Paired box (PAX) 2, a transcription factor, plays a critical role in embryogenesis. When aberrantly expressed in adult tissues, it generally exhibits oncogenic properties. However, the underlying mechanisms remain unclear. We reported previously that the expression of PAX2 was up-regulated in human colon cancers. However, the role of PAX2 in colon cancer cells has yet to be determined. The aim of this study is to determine the function of PAX2 in colon cancer cells and to investigate the possible mechanisms underlain. We find that knockdown of PAX2 inhibits proliferation and xenograft growth of colon cancer cells. Inhibition of PAX2 results in a decreased expression of cyclin D1. Expression of cyclin D1 is found increased in human primary colon malignant tumors, and its expression is associated with that of PAX2. These data indicate that PAX2 is a positive regulator of expression of cyclin D1. We find that knockdown of PAX2 inhibits the activity of AP-1, a transcription factor that induces cyclin D1 expression, implying that PAX2 induces cyclin D1 through AP-1. PAX2 has little effect on expression of AP-1 members including c-Jun, c-Fos, and JunB. Our data show that PAX2 prevents JunB from binding c-Jun and enhances phosphorylation of c-Jun, which may elevate the activity of AP-1. Taken together, these results suggest that PAX2 promotes proliferation of colon cancer cells through AP-1.

Footnotes

  • * This work was supported by the Natural Science Foundation of China (Grant 30970586) and the Innovation Program of the Chinese Academy of Sciences (Grant KSCX2-EW-R-09).

  • Graphic This article contains supplemental Figs. S1–S6.

  • Received July 18, 2012.
  • Revision received November 5, 2012.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 287, 44164-44172.
  1. PDF + Supp Info
  2. Supplemental Data
  3. All Versions of this Article:
    1. M112.401521v1
    2. 287/53/44164 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.